Abstract
To determine whether dose-volume histogram (DVH) parameters are of value in predicting the incidence and grade of radiation pneumonitis (RP) in patients with small cell lung cancer (SCLC) treated with accelerated hyperfractionated concurrent chemoradiation (AHF-CRT). And to clarify whether AHF-CRT influences the risk of RP in comparison with conventionally fractionated concurrent chemoradiation (CF-CRT).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Radiation OncologyBiologyPhysics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
